Patents Assigned to HEXAPHARMATEC CO., LTD.
  • Patent number: 12503451
    Abstract: Provided are a 2-arylthiazole derivative or pharmaceutically acceptable salt thereof having a specific carboxamide moiety, including a substituted aminoalkyl-carboxamide moiety, a N-containing heterocyclic-alkyl-carboxamide moiety, or a N-containing heterocyclic-carboxamide moiety, a process for the preparation thereof, and a pharmaceutical composition comprising the same.
    Type: Grant
    Filed: January 15, 2021
    Date of Patent: December 23, 2025
    Assignee: HEXAPHARMATEC CO., LTD.
    Inventors: Shin Han, Jae-Hyoung Lee
  • Patent number: 12110281
    Abstract: Provided is a novel catechol derivative or pharmaceutically acceptable salt thereof having an alkyl moiety substituted with alkylamino and/or a N-alkyl-substituted thiophene-(thio)carboxamide moiety, a process for the preparation thereof, and a pharmaceutical composition including the same.
    Type: Grant
    Filed: July 17, 2019
    Date of Patent: October 8, 2024
    Assignee: HEXAPHARMATEC CO., LTD.
    Inventors: Shin Han, Jae-Hyoung Lee
  • Publication number: 20230219908
    Abstract: Provided are a 2-arylthiazole derivative or pharmaceutically acceptable salt thereof having a specific carboxamide moiety, including a substituted aminoalkyl-carboxamide moiety, a N-containing heterocyclic-alkyl-carboxamide moiety, or a N-containing heterocyclic-carboxamide moiety, a process for the preparation thereof, and a pharmaceutical composition comprising the same.
    Type: Application
    Filed: January 15, 2021
    Publication date: July 13, 2023
    Applicant: HEXAPHARMATEC CO., LTD.
    Inventors: Shin HAN, Jae-Hyoung LEE
  • Publication number: 20210340119
    Abstract: Provided is a novel catechol derivative or pharmaceutically acceptable salt thereof having an alkyl moiety substituted with alkylamino and/or a N-alkyl-substituted thiophene-(thio)carboxamide moiety, a process for the preparation thereof, and a pharmaceutical composition including the same.
    Type: Application
    Filed: July 17, 2019
    Publication date: November 4, 2021
    Applicant: HEXAPHARMATEC CO., LTD.
    Inventors: Shin HAN, Jae-Hyoung LEE